The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of panobinostat (LBH589) and letrozole in post-menopausal women with metastatic breast cancer.
Winston Tan
Research Funding - Roche/Genentech
Jacob B Allred
No relevant relationships to disclose
Alvaro Moreno-Aspitia
No relevant relationships to disclose
Donald W. Northfelt
No relevant relationships to disclose
James N. Ingle
No relevant relationships to disclose
Edith A. Perez
No relevant relationships to disclose